Sign In
Buy NAOV
$4.02
+0 (+0%)
At Close: Mar 13, 2026
Technology supports the evolution of enteral access from blind procedures to real-time visualized placement Technology supports the evolution of enteral access from blind procedures to real-time visua
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
08:30am, Wednesday, 21'st Jan 2026
Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth Marc Waldman brings over 35 years of commerci
The program will integrate the Company's clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes The program will integrate the Company's clinicall
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
12:30pm, Thursday, 18'th Dec 2025
Peak Medical, ENvue's Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future Market Demand for UroShield® Kit Peak Medical, ENvue's Exclusive Distributo
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'
08:00am, Friday, 12'th Dec 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
Head to Head Review: Veracyte (NASDAQ:VCYT) vs. Nanovibronix (NASDAQ:NAOV)
02:14am, Tuesday, 02'nd Dec 2025
Nanovibronix (NASDAQ: NAOV - Get Free Report) and Veracyte (NASDAQ: VCYT - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the
NanoVibronix Issues Letter to Shareholders
08:00am, Wednesday, 19'th Nov 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today issued a letter
NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities
08:00am, Thursday, 18'th Sep 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
03:57pm, Tuesday, 16'th Sep 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio
08:00am, Monday, 15'th Sep 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio
08:00am, Monday, 15'th Sep 2025
NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today ann
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
08:00am, Thursday, 04'th Sep 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
NanoVibronix Announces Reverse Stock Split
09:00am, Friday, 08'th Aug 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announc
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
09:00am, Friday, 18'th Jul 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices for enteral feeding, pain m
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic systems, today announc
